Literature DB >> 16329164

Molecular cloning and bioinformatics analysis of a novel spliced variant of survivin from human breast cancer cells.

Wenyun Zheng1, Xingyuan Ma, Dongzhi Wei, Tianwen Wang, Yushu Ma, Shengli Yang.   

Abstract

Survivin gene and its two alternatively spliced variants, survivin-2 B and survivin- Delta Ex3 gene were cloned from human breast cancer cell lines B-cap37 firstly. A new gene designated as survivin-image (SI) was cloned from above cell lines, which has not been reported yet to clone from any cell lines. It was found that the novel gene 507 bp comprises partial survivin gene (345 bp), partial image gene (155 bp) of eye cancer and other insertion of 7 bp by analyzing with a series of recent bioinformatics software at the level of nucleotide and protein deduced. Predicted 3-D structures of the new molecule showed greatly similar to that of survivin in N-terminal containing BIR by homology modeling. These results suggested SI gene (GenBank accession No.AY830084) might be a novel alternatively spliced isoforms of the survivin gene involved in other functional significances related to tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16329164     DOI: 10.1080/10425170500226490

Source DB:  PubMed          Journal:  DNA Seq        ISSN: 1026-7913


  9 in total

Review 1.  Survivin study: an update of "what is the next wave"?

Authors:  Fengzhi Li; Xiang Ling
Journal:  J Cell Physiol       Date:  2006-09       Impact factor: 6.384

2.  Survivin promoter -31G/C polymorphism in oral cancer cell lines.

Authors:  Salvatore de Maria; Lorenzo Lo Muzio; Alessandra Braca; Paolo Rega; Amalia Cassano; Angela Vinella; Ruggiero Fumarulo; Rosario Serpico; Ernesto Farina; Vittoria Metafora; Giuseppe Pannone; Gian Pietro Ravagnan; Salvatore Metafora; Corrado Rubini; Maria Carteni; Maria Addolorata Mariggiò
Journal:  Oncol Lett       Date:  2011-07-05       Impact factor: 2.967

3.  Survivin expression in human lung cancer and the influence of its downregulation on the biological behavior of human lung cancer cells.

Authors:  Xiang-Qi Chen; Sheng Yang; Ming-Qiang Kang; Zhi-Ying Li; Hui-Shan Lu; Ting-Yan Lin
Journal:  Exp Ther Med       Date:  2012-03-23       Impact factor: 2.447

Review 4.  Association of survivin splice variants with prognosis and treatment of breast cancer.

Authors:  Anastasia Pavlidou; Christos Kroupis; Kleanthi Dimas
Journal:  World J Clin Oncol       Date:  2014-12-10

5.  Survivin Monoclonal Antibodies Detect Survivin Cell Surface Expression and Inhibit Tumor Growth In Vivo.

Authors:  Robert A Fenstermaker; Sheila A Figel; Jingxin Qiu; Tara A Barone; Sanam S Dharma; Evan K Winograd; Phillip M Galbo; Laura M Wiltsie; Michael J Ciesielski
Journal:  Clin Cancer Res       Date:  2018-03-14       Impact factor: 12.531

6.  Bifunctional roles of survivin-ΔEx3 and survivin-2B for susceptibility to apoptosis in endometrial carcinomas.

Authors:  Yuki Tazo; Atsuko Hara; Takashi Onda; Makoto Saegusa
Journal:  J Cancer Res Clin Oncol       Date:  2014-07-12       Impact factor: 4.553

Review 7.  Survivin splice variants and their diagnostic significance.

Authors:  Nand K Sah; Chandrabhan Seniya
Journal:  Tumour Biol       Date:  2015-08-06

8.  Effects and mechanism of downregulation of survivin expression by RNA interference on proliferation and apoptosis of lung cancer cells.

Authors:  Xiang-Qi Chen; Sheng Yang; Zhi-Ying Li; Hui-Shan Lu; Ming-Qiang Kang; Ting-Yan Lin
Journal:  Mol Med Rep       Date:  2012-01-13       Impact factor: 2.952

9.  Comparative study on the immunogenicity between an HLA-A24-restricted cytotoxic T-cell epitope derived from survivin and that from its splice variant survivin-2B in oral cancer patients.

Authors:  Jun-ichi Kobayashi; Toshihiko Torigoe; Yoshihiko Hirohashi; Satomi Idenoue; Akihiro Miyazaki; Akira Yamaguchi; Hiroyoshi Hiratsuka; Noriyuki Sato
Journal:  J Transl Med       Date:  2009-01-06       Impact factor: 5.531

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.